Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
UK’s Rising Rebate Threatens Branded Generic And Biosimilar Supply
BGMA Warns Of Market Withdrawals And Calls For Government Strategy For Sector
Dec 09 2022
•
By
David Wallace
The rising VPAS rate is putting UK supply at risk • Source: Shutterstock
More from Policy & Regulation
More from Generics Bulletin